Characteristics of non-randomised studies of drug treatments: cross sectional study
The findings of the study suggest that although access to real world evidence could be valuable, the robustness and transparency of non-randomised studies need to be improved.
Authors
- Anna Pellat (ORCID: https://orcid.org/0000-0001-6024-4830)
- Philippe Ravaud (ORCID: https://orcid.org/0000-0001-8264-9206)
- Isabelle Boutron (ORCID: https://orcid.org/0000-0002-5263-6241)
- Raphaël Porcher (ORCID: https://orcid.org/0000-0002-5277-4679)
- Viet-Thi Tran (ORCID: https://orcid.org/0000-0003-1863-6739)
- Sally Yaacoub (ORCID: https://orcid.org/0000-0003-0819-1561)
- Hillary Bonnet
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Sorbonne Université (FR)
- Université Sorbonne Paris Nord (FR)
- Sorbonne Paris Cité (FR)
- Hôpital Cochin (FR)
- Hôtel-Dieu de Paris (FR)
- Centre de Recherche Épidémiologie et Statistique (FR)
- Cochrane (GB)
Publication Details
- Journal
- BMJ Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1136/bmjmed-2024-000932
- Citations
- 8
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 9.03